Molecular assays for antimalarial drug resistance surveillance: A objective product profile.
Antimalarial drug resistance is a major constraint for malaria administration and elimination efforts. Artemisinin-based combination treatment is now the mainstay for malaria remedy. Nonetheless, delayed parasite clearance following remedy with artemisinin derivatives has now unfold inside the Higher Mekong Sub space and can emerge or unfold to totally different malaria endemic areas. This unfold is of good concern for malaria administration programmes, as no choices to artemisinin-based combination therapies are anticipated to be obtainable inside the near future.
- There is a must strengthen surveillance packages for early detection and response to the antimalarial drug resistance threat. Current surveillance is principally executed by therapeutic efficacy analysis; nonetheless these analysis are sophisticated and every time- and resource-intensive.
- For quite a lot of frequent antimalarials, parasite drug resistance has been correlated with specific genetic mutations, and the molecular markers associated to antimalarial drug resistance present a straightforward and extremely efficient instrument to look at the emergence and unfold of resistant parasites.
- Fully totally different strategies to analyse molecular markers associated to antimalarial drug resistance will be discovered, each with advantages and drawbacks. Nonetheless, procedures are often not adequately harmonized to facilitate comparisons between web sites.
- Proper right here we describe the objective product profiles for checks to analyse molecular markers associated to antimalarial drug resistance, give attention to how use of current strategies could also be standardised, and decide the requirements for an excellent product that may allow malaria endemic nations to provide useful spatial and temporal information on the unfold of resistance.
NATtrol Respiratory Verification Panel (20 x 0.25mL) |
|||
| NATRVP-QIA | Zeptometrix | 20 x 0.25mL | EUR 927.36 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Influenza Verification Panel (7 x 1.0 mL) |
|||
| NATFVP-JAN | Zeptometrix | 7 x 1.0 mL | EUR 569.18 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol T.vaginalis Verification Panel (17 x 0.7 mL) |
|||
| NATTVGP-C | Zeptometrix | 17 x 0.7 mL | EUR 722 |
NATtrol CARBA-R Verification Panel (10 x 0.06 mL) |
|||
| NATCRVP-C | Zeptometrix | 10 x 0.06 mL | EUR 267 |
SeroDetect HTLV Ab Verification Panel (5 X 1.5 mL) |
|||
| KZMC011 | Zeptometrix | 5 X 1.5 mL | EUR 334.56 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Influenza/RSV Verification Panel (21 x 0.5mL) |
|||
| NATFRVP-C | Zeptometrix | 21 x 0.5mL | EUR 862 |
SeroDetect HIV-Ab Verification Panel (5 X 1.5 mL) |
|||
| KZMC006 | Zeptometrix | 5 X 1.5 mL | EUR 286 |
NATtrol MTB Verification Panel (5 x 0.6mL, 6 x 1.6mL) |
|||
| NATMTBP-C | Zeptometrix | 5 x 0.6mL, 6 x 1.6mL | EUR 613 |
Influenza Rapid Test Verification Panel (20 X 0.5 mL) |
|||
| KZMC021 | Zeptometrix | 20 X 0.5 mL | EUR 286 |
HIV 1/2 Rapid Test Verification Panel (10 X 0.25 mL) |
|||
| KZMC029 | Zeptometrix | 10 X 0.25 mL | EUR 183 |
SeroDetect Anti-HBs Verification Panel (6 X 1.5 mL) |
|||
| KZMC008 | Zeptometrix | 6 X 1.5 mL | EUR 286 |
SeroDetect Anti-HCV Verification Panel (5 X 1.5 mL) |
|||
| KZMC010 | Zeptometrix | 5 X 1.5 mL | EUR 286 |
Calibration Verification Controls (BG, Electrolyte, Metabolite Analyzers) |
|||
| CVC123 | RNA Medical | each | EUR 565 |
SeroDetect Dengue Fever Verification Panel (9 X 0.5 mL) |
|||
| KZMC028 | Zeptometrix | 10 X 0.5 mL | EUR 277 |
NATtrol Respiratory Verification Panel (RVP) (20 X 0.6 mL) |
|||
| NATRVP-IDI | Zeptometrix | 20 X 0.6 mL | EUR 943 |
NATtrol Respiratory Verification Panel 2 (23 x 0.6mL) (Ea) |
|||
| NATRVP2-BIO | Zeptometrix | 23 x 0.6mL | EUR 1165.73 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) |
|||
| NATRVP2.1-BIO | Zeptometrix | 24 x 0.6mL | EUR 1133 |
SeroDetect Anti-HBcore Verification Panel (5 X 1.5 mL) |
|||
| KZMC009 | Zeptometrix | 5 X 1.5 mL | EUR 334.56 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) |
|||
| NATRVP2-QIA | Zeptometrix | 21 x 0.25mL | EUR 925 |
NATtrol Zika Virus Range Verification Panel (4 x 0.5 mL) |
|||
| NATZIKV-RV | Zeptometrix | 4 x 0.5 mL | EUR 599 |
SeroDetect HIV-Ab Range Verification Panel (10 X 1.5 mL) |
|||
| KZMC024 | Zeptometrix | 10 X 1.5 mL | EUR 286 |
SeroDetect West Nile Virus Verification Panel (10 X 0.5 mL) |
|||
| KZMC027 | Zeptometrix | 10 X 0.5 mL | EUR 334.56 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
NATtrol Respiratory Verification Panel (15 x 0.5mL; 2 x 1mL) |
|||
| NATRVP-NNS | Zeptometrix | 15 x 0.5mL; 2 x 1mL | EUR 784 |
NATtrol Clostridium difficile Verification Panel (6 X 1 mL) |
|||
| NATCDIVP-C | Zeptometrix | 6 X 1 mL | EUR 586 |
NATtrol Zika Virus (PRVABC59) Range Verification Panel (4 x 0.5 mL) |
|||
| NATZIKV(PRV)-RV | Zeptometrix | 4 x 0.5 mL | EUR 599 |
SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL) |
|||
| KZMC022 | Zeptometrix | 15 X 0.25 mL | EUR 269 |
SeroDetect HIV-1/ HIV-2 Ag/Ab Combo Verification Panel (5 X 1.25mL) |
|||
| KZMC030 | Zeptometrix | 5 X 1.25mL | EUR 328 |
ICP-MS Initial Calibration Verification Standard 1 - 125ML |
|||
| CL-ICV-1 | Scientific Laboratory Supplies | 125ML | EUR 548.1 |
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-1Panel | MyBiosource | 1Panel | EUR 850 |
Protein Kinase C, Panel, Western Blot Control (PKC) |
|||
| MBS652621-5x1Panel | MyBiosource | 5x1Panel | EUR 3600 |
Core Panel Multi-Tumor control slides, set of 5 |
|||
| TS900 | Innovex | Set of 5 | EUR 165 |
Core Panel Multi-Tumor control slides, set of 25 |
|||
| TS900-25 | Innovex | Set of 25 | EUR 445 |
Breast Panel Multi-Tumor control slides, set of 5 |
|||
| TS901 | Innovex | Set of 5 | EUR 165 |
Breast Panel Multi-Tumor control slides, set of 25 |
|||
| TS901-25 | Innovex | Set of 25 | EUR 445 |
Control Animal Genomic DNA Panel, Set of any 5 species |
|||
| G-005 | Zyagen | 5X0.025mg | EUR 720 |
Control Animal Genomic DNA Panel, Set of any 10 species |
|||
| G-010 | Zyagen | 10x0.025mg | EUR 1193 |
scFv control Protein, Fc Tag (MALS verified) |
|||
| DNP-H5254 | ACROBIOSYSTEMS | 100ug | EUR 5504.5 |
|
Description: Anti-DNP-scFv, Fc Tag (DNP-H5254) is expressed from human 293 cells (HEK293). It mimics the scFv presented on Anti-DNP. |
|||
Control for ER, 4 cases (1.5mm) HumanBreastBreastIHC control |
|||
| ERC081 | Pantomics | 1 | EUR 50 |
Control for PR, 3 cases (1.5mm) HumanBreastBreastIHC control |
|||
| PRC061 | Pantomics | 1 | EUR 50 |
Control for HER2, 4 cases (1.5mm) HumanBreastBreastIHC control |
|||
| HRC081 | Pantomics | 1 | EUR 50 |
Control for Tyrosinase, 4 cases (1.5mm)HumanskinSkinIHC control |
|||
| TYROSIN081 | Pantomics | 1.5mm | EUR 50 |
Goat IgG (-ve control for flow cytometry) (isotype control) |
|||
| 20011-100 | Alpha Diagnostics | 100 test | EUR 123.6 |
BSA Control for AGE-BSA |
|||
| 35R-AA007 | Fitzgerald | 10 mg | Ask for price |
|
Description: BSA Control for AGE protein (BSA modified), Cat No. 30R-AA007 |
|||
BSA Control for Age-BSA |
|||
| 2221-BSA | Biovision | each | EUR 210 |
Control for Mammaglobin, 4 cases (1.5mm)HumanBreastBreastIHC control |
|||
| MAMA-G081 | Pantomics | 1.5mm | EUR 50 |
Control for GCDFP-15, 4 cases (1.5mm)HumanBreastBreastIHC control |
|||
| GCDFP081 | Pantomics | 1.5mm | EUR 50 |
Negative Control for Mouse IgG1 |
|||
| MC-950 | Kamiya Biomedical Company | NCG01 | Ask for price |
Negative Control for Rabbit IgG |
|||
| PC-124 | Kamiya Biomedical Company | Polyclonal | Ask for price |
Negative Control for Rabbit IgG |
|||
| TA353974 | Origene Technologies GmbH | 100 µl | Ask for price |
Control for MSH2, 4 cases (1.5mm)HumanDigestive systemColonIHC control |
|||
| MSH2081 | Pantomics | 1.5mm | EUR 50 |
Control for Olig2, 4 cases (1.5mm)HumanNervous systemBrainIHC control |
|||
| OLIG2081 | Pantomics | 1.5mm | EUR 50 |
Control Peptide for SNAPtideÒ #520 |
|||
| 525 | List Biological Laboratories | 200nmoles | EUR 600 |
Customized Organic Acids Panel-2 in Urine Lyophilized Control Level 1 |
|||
| ZV-3066-02K1-20 | Zivak Technologies | 1 x 3mL | Ask for price |
Scrambled Control for Pri Peptide |
|||
| 069-78 | PHOENIX PEPTIDE | 200 μg | EUR 160.92 |
Control for PSA, 4 cases (1.5mm)HumanReproductive systemProstateIHC control |
|||
| PSA081 | Pantomics | 1.5mm | EUR 50 |
Control for MSMB, 4 cases (1.5mm)HumanReproductive systemProstateIHC control |
|||
| MSMB081 | Pantomics | 1.5mm | EUR 50 |
STT Negative Control for Gelatinase |
|||
| MBS566511-5mg | MyBiosource | 5mg | EUR 485 |
STT Negative Control for Gelatinase |
|||
| MBS566511-5x5mg | MyBiosource | 5x5mg | EUR 2145 |
Positive Control Set For Autoimmune |
|||
| MBS315464-1Set | MyBiosource | 1Set | EUR 1625 |
Positive Control Set For Autoimmune |
|||
| MBS315464-5x1Set | MyBiosource | 5x1Set | EUR 7150 |
Control for Ubiquitin Affinity Beads |
|||
| CUB02B-beads | Cytoskeleton | 10 assays | EUR 112.32 |
Control for ARG-1, 4 cases (1.5mm)HumanDigestive systemLiverIHC control |
|||
| ARG1081 | Pantomics | 1.5mm | EUR 50 |
Human IgG4 (S108P) Kappa Isotype Control (mAb, MALS verified) |
|||
| DNP-C17P1 | ACROBIOSYSTEMS | 100mg | EUR 174.4 |
|
Description: A hapten is a small molecule that can elicit an immune response only when conjugated with a large carrier such as a protein. Typical haptens include drugs, urushiol, quinone, steroids, etc. Peptides and non-protein antigens usually need conjugating to a carrier protein (such as BSA (bovine serum albumin) or KLH (keyhole limpet hemocyanin) to become good immunogens). Additionally, haptens should be administered with an adjuvant to ensure a high quality immune response. It is important that the hapten design (preserving greatly the chemical structure and spatial conformation of target compound), selection of the appropriate carrier protein and the conjugation method are key conditions for the desired specificity anti-hapten antibodies. We design anti-hapten antibodies based on the HaptenDB information. |
|||
Control for Thyroglobulin, 4 cases (1.5mm)HumanEndocrine systemThyroidIHC control |
|||
| THYRGB081 | Pantomics | 1.5mm | EUR 50 |
Control for BMI-1, 4 cases (1.5mm)HumanRespiratory systemLungIHC control |
|||
| BMI1081 | Pantomics | 1.5mm | EUR 50 |
Positive Control Set for RT-PCR |
|||
| E0820-01 | EURx | 20reactions | EUR 30.52 |
|
Description: Set of primers and synthetic RNA template for positive control of RT-PCR reaction |
|||
Control for CK13, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK13081 | Pantomics | 1.5mm | EUR 50 |
Control for CK14, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK14081 | Pantomics | 1.5mm | EUR 50 |
Control for CK15, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK15081 | Pantomics | 1.5mm | EUR 50 |
Control for CK18, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK18081 | Pantomics | 1.5mm | EUR 50 |
Control for CK19, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK19081 | Pantomics | 1.5mm | EUR 50 |
Control for CK20, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK20081 | Pantomics | 1.5mm | EUR 50 |
Control for CK6, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK6081 | Pantomics | 1.5mm | EUR 50 |
Control for CK8, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CK8081 | Pantomics | 1.5mm | EUR 50 |
Control for Desmin, 4 cases (1.5mm)HumanSoft tissuesMulti-organsIHC control |
|||
| DESMIN081 | Pantomics | 1.5mm | EUR 50 |
Control for CEA, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| CEA081 | Pantomics | 1.5mm | EUR 50 |
Control for EGFR, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| EGFR081 | Pantomics | 1.5mm | EUR 50 |
Control for MUC1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| MUC1081 | Pantomics | 1.5mm | EUR 50 |
Control for PDX1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| PDX1081 | Pantomics | 1.5mm | EUR 50 |
Control for p53, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P53081 | Pantomics | 1.5mm | EUR 50 |
Control for p57, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P57081 | Pantomics | 1.5mm | EUR 50 |
Control for p63, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| P63081 | Pantomics | 1.5mm | EUR 50 |
Control for SOX2, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| SOX2081 | Pantomics | 1.5mm | EUR 50 |
Deer IgG, semi-pure for ELISA (Control, non-immune, isotype control) |
|||
| 20024-2 | Alpha Diagnostics | 100 ug | EUR 270 |
Control for Immunoprecipitation IgG beads |
|||
| CIG01-beads | Cytoskeleton | 10 assays | EUR 115.44 |
Control Peptide for SNAPtide® #521 |
|||
| 526 | List Biological Laboratories | 200nmoles | EUR 600 |
Control FD G6PD for Baebies FINDER |
|||
| K088M-6 | Audit MicroControls | 6 x 1 mL | EUR 194 |
|
Description: Tri-Level |
|||
Control for DOG1, 3 cases (1.5mm) HumanDigestive systemMulti-organsIHC control |
|||
| DOG1061 | Pantomics | 1 | EUR 50 |
Control for NDRG1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| NDRG1081 | Pantomics | 1.5mm | EUR 50 |
Control for S100A9, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| S100A9081 | Pantomics | 1.5mm | EUR 50 |
Extraction Control for Challenging Samples |
|||
| TC-9109-096 | Tetracore | each | EUR 90 |
Mouse IgG negative control for ChIP |
|||
| AS21-4695 | Agrisera AB | 100 µg at 1 µg/µl | EUR 155 |
Control for Ckit, 6 samples (1.5mm) HumanDigestive systemMulti-organsIHC control |
|||
| CKIT061 | Pantomics | 1 | EUR 50 |
Control for ALDH1A1, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| ALDH1081 | Pantomics | 1.5mm | EUR 50 |
Control for Stathmin, 4 cases (1.5mm)HumanMulti-systemMulti-organsIHC control |
|||
| STATHMIN081 | Pantomics | 1.5mm | EUR 50 |
Rabbit IgG negative control for ChIP |
|||
| AS21-4694 | Agrisera AB | 250 µg at 1 µg/µl | EUR 98 |
New Mammalian Objective of Rapamycin (mTOR) Modulators Derived from Pure Product Databases and Marine Extracts by Using Molecular Docking Strategies.
Mammalian objective of rapamycin (mTOR) is a PI3K-related serine/threonine protein kinase that capabilities as a grasp regulator of cellular improvement and metabolism, in response to nutrient and hormonal stimuli.
mTOR capabilities in two distinct complexes-mTORC1 is delicate to rapamycin, whereas, mTORC2 is insensitive to this drug. Deregulation of mTOR’s enzymatic train has roles in most cancers, weight issues, and ageing.
Rapamycin and its chemical derivatives are the solely medication that inhibit the hyperactivity of mTOR, nonetheless fairly a number of undesirable uncomfortable side effects have been described on account of its therapeutic use.
The goal of this analysis was to find out new compounds of pure origin that will end in medication with fewer undesirable uncomfortable side effects. Now now we have used computational strategies (molecular docking and calculated ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) parameters) which have enabled the selection of candidate compounds, derived from marine pure merchandise, SuperNatural II, and ZINC pure merchandise, for inhibitors concentrating on, every, the ATP and the rapamycin binding web sites of mTOR. Now now we have confirmed experimental proof of the inhibitory train of 11 chosen compounds in opposition to mTOR.
Now now we have moreover discovered the inhibitory train of a model new marine extract in opposition to this enzyme. The outcomes have been talked about regarding the necessity to find out new molecules for therapeutic use, significantly in opposition to ageing, and with fewer undesirable uncomfortable side effects.
Molecular cloning and expression analysis of three ThERFs involved inside the response to waterlogging stress of Taxodium ‘Zhongshanshan406’, and subcellular localization of the gene merchandise.
As a subfamily of the APETALA 2/ethylene response issue binding protein (AP2/EREBP) transcription concern superfamily, the ethylene response concern (ERF) is broadly involved inside the regulation of improvement and response to different abiotic stresses in vegetation, and has been confirmed to be the precept transcription concern regulating transcription of the genes related to hypoxia and waterlogging stress.
- On this analysis, three ThERF genes, with very important variations in expression profile in response to flooding stress, had been acknowledged from the transcriptomics info acquired from Taxodium hybrid ‘Zhongshanshan 406’ (T. mucronatum Tenore × T. distichum (L.) Rich) beneath waterlogging stress: ThERF15, ThERF39 and ThRAP2.3 (GenBank ID: KY463467, KY463468 and KY463470, respectively).
- The entire-length cDNA of each of the three ERFs was obtained using the RACE (quick amplification cDNA ends) methodology, and all three had been intron-free. Numerous protein sequence alignments indicated that ThERF15, ThERF39 and ThRAP2.Three proteins all had only one AP2-ERF space and belonged to the ERF subfamily.
- A transient gene expression assay demonstrated that ThERF15, ThERF39 and ThRAP2.Three had been all localized to the nucleus. Precise-time quantitative PCR (qPCR) revealed that the expression of ThERF15, ThERF39 and ThRAP2.Three exhibited very important variations, in distinction with the administration, in response to 2 ranges of flooding remedy (half-flooding or total-submergence) of ‘Zhongshanshan 406’.
- Quantification of ethylene focus revealed that ethylene was further associated to the extent of expression than the interval of flooding remedy. Based mostly totally on the experimental outcomes above, ThERF15, ThERF39 and ThRAP2.Three had been acknowledged as being related to the regulation of downstream flooding- responsive gene expression in ‘Zhongshanshan 406’. ThRAP2.Three is nearly actually to be a key downstream-response ERF gene to reply the output of the ethylene signal generated by flooding stress
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
| 0-120-0016 | Biologics | 13 mm | EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
| 0-120-0017 | Biologics | 19 mm | EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
| 0-120-0018 | Biologics | 25 mm | EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
| 00021 | Biotium | 1MG | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 1 mg |
|||
| 00021-1 | Biotium | 20ST | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 20x50 ug |
|||
| 00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
| 00022 | Biotium | 1MG | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 1 mg |
|||
| 00022-1 | Biotium | 20ST | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 20x50 ug |
|||
| 00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023 | Biotium | 1MG | EUR 285 |
|
Description: N/A |
|||
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023-1 | Biotium | EA | EUR 285 |
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 100 |
|
Description: N/A |
|||
Staurosporine |
|||
| 00025-1 | Biotium | EA | EUR 100 |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026 | Biotium | 500uG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®543, 100 ug |
|||
| 00026-100ug | Biotium | 1UG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Rhodamine Phalloidin 300U |
|||
| 00027 | Biotium | 300 | EUR 364 |
|
Description: N/A |
|||